GGrantIndex
← Leaderboards

Neil A Martinson

Wits Health Consortium (Pty), Ltd

$7,090,642
Attributed
$11,770,670
Total exposure
4
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY200725
$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,770,670 · 4

By mechanism

R01$7,210,922 · 2
U01$2,653,805 · 1
U2R$1,905,943 · 1

Top collaborators

Others in their field

Top investigators on “South Africa

Research focus

South AfricaTuberculosisPrevalenceLinkCountryProgramsSuccessScreeningIncidenceRandomizedHigh RiskParticipantGuidelinesAfricanFacultyCost EffectiveCostCost EffectivenessAdultCaringEvidence Based InterventionEpidemiologyBaseCause Of Death

Grant awards (22)

Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness.$371,257
U01 · FY2025 · CA
Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness.$363,472
U01 · FY2025 · CA
Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness.$465,107
U01 · FY2024 · CA
Differentially Culturable Tubercle Bacteria: The missing link in TB Transmission?$844,062
R01 · FY2023 · AI
Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness.$167,600
U01 · FY2023 · CA
Differentially Culturable Tubercle Bacteria: The missing link in TB Transmission?$1,012,392
R01 · FY2022 · AI
Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness.$612,893
U01 · FY2022 · CA
Differentially Culturable Tubercle Bacteria: The missing link in TB Transmission?$982,397
R01 · FY2021 · AI
Evaluating smoking cessation interventions for PWH in South Africa: Efficacy, implementation, and cost-effectiveness.$673,476
U01 · FY2021 · CA
Active_Case_Finding_Testing_and_Linkage_to_Treatment_and_Improved_Survival_(ACTTIS)_Study$504,670
R01 · FY2021 · AI · contact PI
Differentially Culturable Tubercle Bacteria: The missing link in TB Transmission?$964,219
R01 · FY2020 · AI
Active Case Finding Testing and Linkage to Treatment and Improved Survival (ACTTIS) Study$514,917
R01 · FY2020 · AI · contact PI
Differentially Culturable Tubercle Bacteria: The missing link in TB Transmission?$827,855
R01 · FY2019 · AI
Active_Case_Finding_Testing_and_Linkage_to_Treatment_and_Improved_Survival_(ACTTIS)_Study$490,414
R01 · FY2019 · AI · contact PI
Active_Case_Finding_Testing_and_Linkage_to_Treatment_and_Improved_Survival_(ACTTIS)_Study$527,752
R01 · FY2018 · AI · contact PI
Active_Case_Finding_Testing_and_Linkage_to_Treatment_and_Improved_Survival_(ACTTIS)_Study$542,244
R01 · FY2017 · AI · contact PI
South Africa Tuberculosis AIDS Training (SATBAT)$342,749
U2R · FY2011 · TW · contact PI
South Africa Tuberculosis AIDS Training (SATBAT)$300,000
U2R · FY2011 · TW · contact PI
South Africa Tuberculosis AIDS Training (SATBAT)$344,843
U2R · FY2010 · TW · contact PI
South Africa Tuberculosis AIDS Training (SATBAT)$346,866
U2R · FY2009 · TW · contact PI
South Africa Tuberculosis AIDS Training (SATBAT)$291,501
U2R · FY2008 · TW · contact PI
South Africa Tuberculosis AIDS Training (SATBAT)$279,984
U2R · FY2007 · TW · contact PI